FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018332357> ?p ?o ?g. }

• W2018332357 endingPage "1881" @default.
• W2018332357 startingPage "1874" @default.
• W2018332357 abstract "Previous studies have demonstrated beneficial effects of GH replacement, in adults with GH deficiency (GHD), on body composition, physical fitness, and quality of life. These studies, however, concern patients with adult-onset GHD or childhood-onset (CO) patients enrolled several years after withdrawal of initial therapy. So far, the effects of continuation of GH-administration in patients with CO-GHD have not been examined. We studied a group of nineteen young adults (13 males + 6 females; 16-26 yr old; mean age, 20.2 +/- 0.65 yr) with CO-GHD, in a randomized, parallel, double-blind, placebo-controlled trial for 1 yr, followed by an open phase with GH for 1 yr. All patients received GH therapy at the start of study, and trial medication (GH/placebo) was given in a similar dose. Patients randomized to continued GH treatment exhibited no significant changes in any parameters tested, but intra- and interindividual variations in insulin-like growth factor (IGF)-I levels could suggest compliance problems. Discontinuation of GH for 1 yr resulted in a decrease in serum IGF-I, from 422.0 +/- 56.8 to 147.8 +/- 33.4 microg/L, in the placebo group (P = 0.003). After discontinuation of GH for 1 yr, an increase in total body fat (TBF, kg), measured by dual-energy x-ray absorptiometry scan, was seen [placebo: 22.7 +/- 2.7 to 26.5 +/- 2.5 (P = 0.01); GH: 16.2 +/- 2.1 to 17.2 +/- 2.1 (not significant)]. Resumption of GH after placebo was followed by increments in serum IGF-I (microg/L) [from 147.8 +/- 33.4 to 452 +/- 76 (P = 0.001)] and IGF-binding protein 3, as well as in fasting glucose (mmol/L) [4.9 +/- 0.2 vs. 5.3 +/- 0.2 (P = 0.03)]. After resumption of GH lean body mass (kg) increased [52.4 +/- 4.9 vs. 60.7 +/- 5.6 (P = 0.006)]. Likewise, resumption of GH therapy increased thigh muscle volume and thigh muscle/fat ratio, as assessed by computed tomography [muscle volume (cm2/10 mm): 118.2 +/- 11.7 vs. 130.0 +/- 10.9 (P = 0.002); muscle/fat ratio: 1.33 +/- 0.24 vs. 1.69 +/- 0.36 (P = 0.02)]. In conclusion, discontinuation of GH treatment in GHD patients, during the transition from childhood to adulthood, induces significant and potentially unfavorable changes in IGF-I and body composition, both of which are reversed after resumption of GH treatment. By contrast, continuation of GH therapy results in unaltered IGF-I and body composition. We recommend continuation of GH therapy in these patients, to be undertaken in collaboration between pediatricians and adult endocrinologists." @default.
• W2018332357 created "2016-06-24" @default.
• W2018332357 creator A5042510303 @default.
• W2018332357 creator A5045917807 @default.
• W2018332357 creator A5066686056 @default.
• W2018332357 creator A5081123168 @default.
• W2018332357 creator A5083229910 @default.
• W2018332357 creator A5090850055 @default.
• W2018332357 date "2000-05-01" @default.
• W2018332357 modified "2023-10-03" @default.
• W2018332357 title "Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled Study" @default.
• W2018332357 cites W1966154291 @default.
• W2018332357 cites W1968696892 @default.
• W2018332357 cites W1977660546 @default.
• W2018332357 cites W1983654189 @default.
• W2018332357 cites W1984155300 @default.
• W2018332357 cites W1990524920 @default.
• W2018332357 cites W1998765364 @default.
• W2018332357 cites W1999848620 @default.
• W2018332357 cites W2000607618 @default.
• W2018332357 cites W2005892622 @default.
• W2018332357 cites W2006074731 @default.
• W2018332357 cites W2009517655 @default.
• W2018332357 cites W2030851340 @default.
• W2018332357 cites W2049776119 @default.
• W2018332357 cites W2063854461 @default.
• W2018332357 cites W2070283543 @default.
• W2018332357 cites W2074022842 @default.
• W2018332357 cites W2078731699 @default.
• W2018332357 cites W2078839377 @default.
• W2018332357 cites W2084943244 @default.
• W2018332357 cites W2089262859 @default.
• W2018332357 cites W2107838248 @default.
• W2018332357 cites W2115251391 @default.
• W2018332357 cites W2116404316 @default.
• W2018332357 cites W2144425974 @default.
• W2018332357 cites W2146352480 @default.
• W2018332357 cites W2159058445 @default.
• W2018332357 cites W2161622680 @default.
• W2018332357 cites W2166006787 @default.
• W2018332357 cites W4249309281 @default.
• W2018332357 doi "https://doi.org/10.1210/jcem.85.5.6598" @default.
• W2018332357 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10843168" @default.
• W2018332357 hasPublicationYear "2000" @default.
• W2018332357 type Work @default.
• W2018332357 sameAs 2018332357 @default.
• W2018332357 citedByCount "91" @default.
• W2018332357 countsByYear W20183323572012 @default.
• W2018332357 countsByYear W20183323572013 @default.
• W2018332357 countsByYear W20183323572014 @default.
• W2018332357 countsByYear W20183323572015 @default.
• W2018332357 countsByYear W20183323572016 @default.
• W2018332357 countsByYear W20183323572017 @default.
• W2018332357 countsByYear W20183323572018 @default.
• W2018332357 countsByYear W20183323572019 @default.
• W2018332357 countsByYear W20183323572021 @default.
• W2018332357 countsByYear W20183323572022 @default.
• W2018332357 crossrefType "journal-article" @default.
• W2018332357 hasAuthorship W2018332357A5042510303 @default.
• W2018332357 hasAuthorship W2018332357A5045917807 @default.
• W2018332357 hasAuthorship W2018332357A5066686056 @default.
• W2018332357 hasAuthorship W2018332357A5081123168 @default.
• W2018332357 hasAuthorship W2018332357A5083229910 @default.
• W2018332357 hasAuthorship W2018332357A5090850055 @default.
• W2018332357 hasBestOaLocation W20183323571 @default.
• W2018332357 hasConcept C126322002 @default.
• W2018332357 hasConcept C134018914 @default.
• W2018332357 hasConcept C142724271 @default.
• W2018332357 hasConcept C204787440 @default.
• W2018332357 hasConcept C27081682 @default.
• W2018332357 hasConcept C2778715236 @default.
• W2018332357 hasConcept C2779952775 @default.
• W2018332357 hasConcept C2910954651 @default.
• W2018332357 hasConcept C2984496839 @default.
• W2018332357 hasConcept C71315377 @default.
• W2018332357 hasConcept C71924100 @default.
• W2018332357 hasConceptScore W2018332357C126322002 @default.
• W2018332357 hasConceptScore W2018332357C134018914 @default.
• W2018332357 hasConceptScore W2018332357C142724271 @default.
• W2018332357 hasConceptScore W2018332357C204787440 @default.
• W2018332357 hasConceptScore W2018332357C27081682 @default.
• W2018332357 hasConceptScore W2018332357C2778715236 @default.
• W2018332357 hasConceptScore W2018332357C2779952775 @default.
• W2018332357 hasConceptScore W2018332357C2910954651 @default.
• W2018332357 hasConceptScore W2018332357C2984496839 @default.
• W2018332357 hasConceptScore W2018332357C71315377 @default.
• W2018332357 hasConceptScore W2018332357C71924100 @default.
• W2018332357 hasIssue "5" @default.
• W2018332357 hasLocation W20183323571 @default.
• W2018332357 hasLocation W20183323572 @default.
• W2018332357 hasOpenAccess W2018332357 @default.
• W2018332357 hasPrimaryLocation W20183323571 @default.
• W2018332357 hasRelatedWork W1965734652 @default.
• W2018332357 hasRelatedWork W1982197179 @default.
• W2018332357 hasRelatedWork W1984505489 @default.
• W2018332357 hasRelatedWork W2004932323 @default.
• W2018332357 hasRelatedWork W2144329099 @default.
• W2018332357 hasRelatedWork W2157270853 @default.

• next